The Company is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is engaged in the manufacture and sale of antipyretic analgesic anti-inflammatory drugs, digestive system drugs, central nervous system drugs, nutritional supplements and other pharmaceuticals. In addition, the Company is engaged in the sale of medical devices and health functional foods. The Company was founded on March 25, 1986, and its shares are listed on KONEX Exchange on July 20, 2022.

Headquarters
354, Wondang-Ro, Wongok-Myeon
Anseong; Gyeonggi;

Contact Details: Purchase the Baskhanbiopharma Inc. report to view the information.

Website: http://www.baskhanbio.com

Basic Information

Total Employees:

Purchase the Baskhanbiopharma Inc. report to view the information.

Outstanding Shares:

Purchase the Baskhanbiopharma Inc. report to view the information.

Financial Auditors:

Purchase the Baskhanbiopharma Inc. report to view the information.

Incorporation Date:

March 20, 1986

Company Performance

Financial values in the chart are available after Baskhanbiopharma Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

-5.16%▼

Total Operating Revenue

-3.96%▼

Operating Profit

31.88%▲

EBITDA

10.32%▲

Net Profit/Loss for the Period

0.68%▲

Total Assets

6.97%▲

Total Equity

10.18%▲

Operating Profit Margin

1.6%▲

Net Profit Margin

0.57%▲

Return on Equity (ROE)

-0.88%▼

Debt / Equity

0.13%▲

Quick Ratio

1.79%▲

Cash Ratio

1.24%▲

Baskhanbiopharma Inc. (South Korea)